Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 51 to 59 of 59 results for adhd

  1. Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate (ESNM19)

    This evidence summary has been updated and replaced by NICE guideline NG87.

    Evidence summary
    Published
    7 May 2013

  2. Attention deficit hyperactivity disorder in children and young people: clonidine (ESUOM8)

    This evidence summary has been updated and replaced by NICE guideline NG87.

    Evidence summary
    Published
    2 April 2013

  3. Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin (ESUOM2)

    This evidence summary has been withdrawn because licensed products are now available.

    Evidence summary
    Published
    4 January 2013

  4. Social and emotional wellbeing: early years (PH40)

    This guideline covers supporting the social and emotional wellbeing of vulnerable children under 5 through home visiting, childcare and early education. It aims to optimise care for young children who need extra support because they have or are at risk of social or emotional problems.

    Public health guideline
    Published
    24 October 2012
    View recommendations

    Sections for PH40

  5. Attention deficit hyperactivity disorder: diagnosis and management (CG72)

    This guidance has been updated and replaced by NICE guideline NG87.

    Clinical guideline
    Published
    24 September 2008

  6. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (TA98)

    This guidance has been updated and replaced by NICE guideline NG87.

    Technology appraisal guidance
    Published
    22 March 2006

  7. Methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents (TA13)

    This guidance has been replaced by NICE technology appraisal guidance 98 [Replaced by NICE guideline NG87].  

    Technology appraisal guidance
    Published
    28 October 2000

  8. Technologies for the assessment of attention deficit hyperactivity disorder (ADHD)

    In development [GID-DG10088] Expected publication date: TBC

    Diagnostics guidance
    In development

  9. Attention deficit disorder

    All NICE products on attention deficit disorder. Includes any guidance, advice and quality standards.

    Topic page